3,4-DAA
|
- $18 - $631
- Product name: 3,4-DAA
- CAS: 2117759-07-4
- MF: C18H17NO6
- MW: 343.33068
- EINECS:
- MDL Number:
- Synonyms:3,4-DAA
7 prices
Selected condition：
Brand
- ApexBio Technology
- Cayman Chemical
Package
- 1mg
- 5mg
- 10mg
- 50mg
- ManufacturerApexBio Technology
- Product numberB7827
- Product description3,4-DAA
- Packaging5mg
- Price$82
- Updated2021-12-16
- Buy
- ManufacturerApexBio Technology
- Product numberB7827
- Product description3,4-DAA
- Packaging10mg
- Price$145
- Updated2021-12-16
- Buy
- ManufacturerApexBio Technology
- Product numberB7827
- Product description3,4-DAA
- Packaging50mg
- Price$631
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number10007980
- Product description3,4-DAA ≥95%
- Packaging1mg
- Price$18
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number10007980
- Product description3,4-DAA ≥95%
- Packaging5mg
- Price$73
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number10007980
- Product description3,4-DAA ≥95%
- Packaging10mg
- Price$129
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number10007980
- Product description3,4-DAA ≥95%
- Packaging50mg
- Price$553
- Updated2024-03-01
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| ApexBio Technology | B7827 | 3,4-DAA | 5mg | $82 | 2021-12-16 | Buy |
| ApexBio Technology | B7827 | 3,4-DAA | 10mg | $145 | 2021-12-16 | Buy |
| ApexBio Technology | B7827 | 3,4-DAA | 50mg | $631 | 2021-12-16 | Buy |
| Cayman Chemical | 10007980 | 3,4-DAA ≥95% | 1mg | $18 | 2024-03-01 | Buy |
| Cayman Chemical | 10007980 | 3,4-DAA ≥95% | 5mg | $73 | 2024-03-01 | Buy |
| Cayman Chemical | 10007980 | 3,4-DAA ≥95% | 10mg | $129 | 2024-03-01 | Buy |
| Cayman Chemical | 10007980 | 3,4-DAA ≥95% | 50mg | $553 | 2024-03-01 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|